Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v10-EN
Language French English
Date Updated 2019-11-28 2019-11-28
Drug Identification Number 02139561 02139561
Brand name OXYTOCIN INJECTION OXYTOCIN INJECTION
Common or Proper name Oxytocin Injection Oxytocin Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients OXYTOCIN OXYTOCIN
Strength(s) 10UNIT 10UNIT
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 1mL 1mL
ATC code H01BB H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-30 2019-09-30
Estimated end date 2019-11-08 2019-11-08
Actual end date 2019-11-08 2019-11-08
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Stock Available Stock Available
Health Canada comments